Abstract

Background: Omega-3 fatty acids are associated with a lower risk of cardiovascular disease (CVD) and with beneficial effects on CV risk factors. The albumin-creatinine ratio (ACR) is a risk factor for CVD, all-cause mortality and accelerated glomerular filtration rate (GFR) decline in the general population. We aimed to investigate the association between n-3 PUFAS and ACR in heathy individuals with preserved GFR.Design and Methods: The present cross-sectional analysis is part of the GAPP study, a population-based cohort of healthy adults aged 25–41 years. Individuals with known CVD, diabetes, or a BMI >35 kg/m2 were excluded. eGFR was calculated according to the combined Creatinine/Cystatin C CKD-EPI formula. ACR was obtained from a fasting morning urine sample. The Omega-3 Index (relative amount of EPA and DHA of total fatty acids in %) was obtained from whole blood aliquots.Results: Overall, 2001 participants (median age 37 years IQR 31; 40, 53% female) were included in this analysis. Median Omega-3 Index was 4.59 (IQR 4.06; 5.25) and median eGFR 111 ml/min/1.73 m2 (IQR 103; 118). Median ACR was 0.14 mg/mmol (IQR 0; 0.43). We found a significant inverse association of the Omega-3 Index with ACR (ratio 0.84, 95%CI 0.73–0.96; p = 0.011) which remained after comprehensive adjustment (ratio 0.86, 95%CI 0.74–1.00; p = 0.048). No association of the Omega-3 Index with eGFR was found. The adjusted difference in eGFR per 1-unit increase in Omega3-Index was −0.21 (95%CI −0.76; 0.35; p = 0.47).Conclusions: A higher Omega-3 Index was significantly associated with lower ACR in this young and healthy population with preserved eGFR. Omega-3 fatty acids may exhibit cardio- and nephroprotective effects in healthy individuals through modulation of ACR.

Highlights

  • Omega-3 polyunsaturated fatty acids (n-3 PUFAs) include the fish-derived eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) as well as alpha-linolenic acid (ALA) derived from plants

  • In animal models dietary supplementation with n-3 PUFAs slows the progression of kidney disease and reduces urine albumin excretion as well as renal inflammation and fibrosis [7, 8]

  • Data form interventional trials showed the potential of n-3 PUFA supplementation to attenuate the progression of albuminuria in individuals with type 2 diabetes and coronary heart disease [10]

Read more

Summary

Introduction

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) include the fish-derived eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) as well as alpha-linolenic acid (ALA) derived from plants Their beneficial effect on cardiovascular disease and risk factors has been the focus of a multitude of experimental studies and clinical investigations. Data form interventional trials showed the potential of n-3 PUFA supplementation to attenuate the progression of albuminuria in individuals with type 2 diabetes and coronary heart disease [10]. Data from both observational and interventional trials lack in healthy individuals free of cardiovascular disease—where long-term prevention efforts may be effective. We aimed to investigate the association between n-3 PUFAS and ACR in heathy individuals with preserved GFR

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call